Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis
- 19 February 2008
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 255 (4), 545-550
- https://doi.org/10.1007/s00415-008-0738-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- DroolingCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2006
- Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled studyMovement Disorders, 2006
- Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparationsEuropean Journal of Neurology, 2006
- Aplicação de toxina botulínica tipo A para reduzir a saliva em pacientes com esclerose lateral amiotróficaRevista Brasileira de Otorrinolaringologia, 2005
- Controlling sialorrhoea: a review of available treatment optionsExpert Opinion on Pharmacotherapy, 2005
- Reduction of Salivary Flow With Botulinum Toxin: Extended Report on 33 Patients with Drooling, Salivary Fistulas, and SialadenitisThe Laryngoscope, 2004
- Botulinum toxin B reduces sialorrhea in parkinsonismMovement Disorders, 2003
- Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonismMovement Disorders, 2003
- Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disordersJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Method for the Collection of Separate Submaxillary and Sublingual Salivas in ManJournal of Dental Research, 1955